1,2-dipalmitoylphosphatidylglycerol has been researched along with paclitaxel in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, KW; Hilt, JZ; Mansour, HM; McGarry, RC; Meenach, SA | 1 |
1 other study(ies) available for 1,2-dipalmitoylphosphatidylglycerol and paclitaxel
| Article | Year |
|---|---|
High-performing dry powder inhalers of paclitaxel DPPC/DPPG lung surfactant-mimic multifunctional particles in lung cancer: physicochemical characterization, in vitro aerosol dispersion, and cellular studies.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Antineoplastic Agents; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Crystallography, X-Ray; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Dry Powder Inhalers; Electric Impedance; Equipment Design; Humans; Lung Neoplasms; Microscopy, Fluorescence; Paclitaxel; Particle Size; Phosphatidylglycerols; Powder Diffraction; Powders; Solubility; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Surface Properties; Technology, Pharmaceutical; Time Factors | 2014 |